Ventricular dysfunction in a family with long QT syndrome type 3

Europace

Volumn 15, Issue 10, 2013, Pages 1516-1521

  Hummel, Yoran M ^a   Wilde, Arthur A M ^b   Voors, Adriaan A ^a   Bugatti, Silvia ^c   Hillege, Hans L ^a   Van Den Berg, Maarten P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Echocardiography; Long QT syndrome; Persistent inward current; Post systolic shortening; SCN5a; Sodium channel; Speckle tracking

Indexed keywords

SODIUM CHANNEL NAV1.5;

ADULT; ARTICLE; BRUGADA SYNDROME; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUMAN; LONG QT SYNDROME 3; MALE; MYOCARDIAL DISEASE; PHENOTYPE; PRIORITY JOURNAL; SODIUM CHANNELOPATHY; SODIUM CURRENT; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; LONG QT SYNDROME; PERSISTENT INWARD CURRENT; POST-SYSTOLIC SHORTENING; SCN5A; SODIUM CHANNEL; SPECKLE TRACKING;

ADULT; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; LONG QT SYNDROME; MALE; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; PEDIGREE; PHENOTYPE; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84884990853     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut101     Document Type: Article

References (34)

1. Nador F, Beria G, De Ferrari GM, Stramba-Badaiale M, Locati EH, Lotto A et al. Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications. Circulation 1991;84:1530-42.
2. De Ferrari GM, Nador F, Beria G, Sala S, Lotto A, Schwartz PJ. Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome. Circulation 1994;89:2126-32.
3. Haugaa KH, Edvardsen T, Leren TP, Gran JM, Smiseth OA, Amlie JP. Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur Heart J 2009;30:330-7.
4. Haugaa KH, Amlie JP, Berge KE, Leren TP, Smiseth OA, Edvardsen T. Transmural differences in myocardial contraction in long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation 2010;122:1355-63.
5. Bezzina CR, RookMB, GroenwegenWA, Herfst LJ, van derWalAC,LamJ et al.Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003;92:159-68.
6. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005;112:2769-77.
7. McNair WP, Ku L, Taylor MR, Fain PR, Dao D,Wolfel E et al. Familial Cardiomyopathy Registry Research Group: SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110:2163-7.
8. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447-54.
9. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005;112:3680-7.
10. Ge J, Sun A, Paajanen V,Wang S, Su C, Yang Z et al. Molecular and clinical characterization of a novelSCN5Amutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2008;1:83-92.
11. Shi R, Zhang Y, Yang C, Huang C, Zhou X, QiangHet al. The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death. Europace 2008;10:1329-35.
12. McNair WP, Sinagra G, Taylor MRG, Di Lenarda A, Ferguson DA, Salcedo EE et al. Familial Cardiomyopathy Registry Research Group: SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltagesensing mechanism. J Am Coll Cardiol 2011;57:2160-8.
13. Bezzina CR, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma JW et al. A single sodium channel mutation causing both long QT- and Brugada syndromes. Circ Res 1999;85:1206-13.
14. van den Berg MP, Wilde AAM, Viersma JW, Brouwer J, Haaksma J, van der Hout AH et al. Possible bradycardic mode of death and succesful pacemaker treatment in a large family with features of both long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:630-6.
15. Postema PG, van den Berg MP, van Tintelen JP, van den Heuvel F, Grundeken M, Hofman N et al. Founder mutations in the Netherlands -SCN5a 1795insD, the first described overlap syndrome - one of the largest and best characterised families worldwide. Neth Heart J 2009;17:422-8.
16. Brouwer CAJ, Postma A, Vonk JM, Zwart N, van den Berg MP, Bink-Boelkens MT et al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. Eur J Cancer 2011;47:2453-62.
17. Nagueh SF, Appleton CP, Gillebert TC, Marino PN,OhJK, SmisethOAet al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology: recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
19. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr 2009;22: 776-92.
20. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011;12:167-205.
21. Voigt JU, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U et al. Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc Echocardiogr 2003;16: 415-23.
22. Morad M, TrautweinW.The effect of the duration of the action potential on contraction in the mammalian heart muscle. Arch Gesamte Physiol Menschen Tiere 1968;299: 66-82.
23. Morad M, Orkand RK. Excitation-concentration coupling in frog ventricle: evidence from voltage clamp studies. J Physiol 1971;219:167-89.
24. Arreola J, Dirksen RT, Shieh RC, Willeford DJ, Sheu SS. Ca2+ current and Ca2+ transients under action potential clamp in guinea pig ventricular myocytes. Am J Physiol 1991;261:C393-7.
25. Remme CA, Verkerk AO, Nuyens D, van Ginneken AC, van Brunschot S, Belterman CN et al. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 2006; 114:2584-94.
26. Moss AJ, ZarebaW, SchwarzKQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 2008;19:1289-93.
27. Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K et al. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 2010;55:2330-42.
28. Sossalla S,Wagner S, Rasenack EC, Ruff H,Weber SL, Schöndube FA et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 2008;45:32-43.
29. Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F et al. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 2013;127:575-84.
30. van Veen TA, Stein M, Royer A, Le Quang K, Charpentier F, Colledge WH et al. Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 2005;112:1927-35.
31. van Hoorn F, Campian ME, Spijkerboer A, Blom MT, Planken RN, van Rossum AC et al. SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility. PLoS ONE 2012;7:e42037.
32. Tessa C, Del Maglio J, Ghidini Ottonelli A, Diciotti S, Salvatori L, Magnacca M et al. Evaluation of Brugada syndrome by cardiac magnetic resonance. Int J Cardiovasc Imaging 2012;28:1961-70.
33. SmitMD,van Dessel PF, NieuwlandW, WiesfeldAC, Tan ES, Anthonio RL et al. Right ventricular pacing and the risk of heart failure in implantable cardioverterdefibrillator patients. Heart Rhythm 2006;3:1397-403.
34. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB et al. DAVID Investigators: Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-4.